Bright Minds Biosciences: Piper Sandler cuts target price to $115 from $220
DRUG•Piper Sandler cut its price target for Bright Minds Biosciences to $115 from $220.
Related News
TPG Inc.: BofA Global Research raises price objective to $65 from $58
TPG•
Circle Internet Group target price raised to $110 from $105 by JP Morgan
CRCL•
Coinbase Global: BofA Global Research cuts price objective to $177 from $203
COIN•
Inspire Medical Systems: Piper Sandler raises target price to $70 from $60
INSP•
Progressive target price raised to $261 from $238
PGR•